ProShare Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.2K | Sell |
|
|||||
|
2025
Q1 | $88K | Sell |
|
|||||
|
2024
Q4 | $118K | Buy |
|
|||||
|
2024
Q3 | $131K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $240K | Buy |
|
|||||
|
2023
Q4 | $189K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $223K | Buy |
|
|||||
|
2022
Q3 | $240K | Buy |
|
|||||
|
2022
Q2 | $221K | Sell |
|
|||||
|
2022
Q1 | $436K | Sell |
|
|||||
|
2021
Q4 | $518K | Buy |
|
|||||
|
2021
Q3 | $634K | Sell |
|
|||||
|
2021
Q2 | $731K | Buy |
|
|||||
|
2021
Q1 | $587K | Buy |
|
|||||
|
2020
Q4 | $630K | Buy |
|
|||||
|
2020
Q3 | $295K | Sell |
|
|||||
|
2020
Q2 | $409K | Buy |
|
|||||
|
2020
Q1 | $244K | Sell |
|
|||||
|
2019
Q4 | $547K | Sell |
|
|||||
|
2019
Q3 | $518K | Sell |
|
|||||
|
2019
Q2 | $769K | Sell |
|
|||||
|
2019
Q1 | $959K | Buy |
|
|||||
|
2018
Q4 | $687K | Sell |
|
|||||
|
2018
Q3 | $1.44M | Buy |
|
|||||
|
2018
Q2 | $1.29M | Buy |
|
|||||
|
2018
Q1 | $536K | Sell |
|
|||||
|
2017
Q4 | $694K | Buy |
|
|||||
|
2017
Q3 | $636K | Buy |
|
|||||
|
2017
Q2 | $360K | Buy |
|
|||||
|
2017
Q1 | $318K | Sell |
|
|||||
|
2016
Q4 | $385K | Buy |
|